title: [Effect of xuebijing oral effervescent tablet on endotoxin induced fever and disseminated intravascular coagulation rabbit model].
abstract: In order to discover the mechanism of Xuebijing oral effervescent tablet (XBJOET) to treat infectious diseases, the effect of XBJOET on endotoxin induced rabbit fever and disseminated intravascular coagulation (DIC) was investigated. Auricle microcirculation in rabbit was detected by laser speckle blood perfusion imager system; coagulation function was measured by coagulation analyzer, fibrinolytic system was quantified by Elisa assay and micro thrombosis in tissues was observed with HE staining under light microscope. The results demonstrated that the body temperature of rabbit decreased significantly at 1-3 h after administration with 4.8, 2.4 and 1.2 g x kg(-1) XBJOET to endotoxin induced DIC rabbit model, the auricle microcirculation blood flow in model group (54.45 +/- 14.53) PU was lower than that in control group (77.18 +/- 12.32) PU. The auricle microcirculation blood flow increased markedly and there was significant difference between model group and 1.2 g x kg(-1) XBJOET group. There was significant difference between model group and control group in the content of PAI1 and FIB. The PAI1 levels in model and control groups were (30.48 +/- 2.46) ng x mL(-1) and (20.93 +/- 3.25) ng x mL(-1), respectively. The FIB levels in model and control group were (3.34 +/- 1.09) g x L(-1) and (4.84 +/- 1.10) g x L(-1), respectively. The content of PAI1 in rabbit plasma decreased notably, there were significant differences between model group and 4.8, 2.4 g x kg(-1) XBJOET groups. On the contrary the content of FIB increased. XBJOET possessed pharmacological activities of curing infectious fever and DIC, the mechanism of which is related to amelioration of microcirculation disturbance, inhibition of fibrinolytic system activation and coagulation and micro thrombosis elimination.
authors.affiliation: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
authors.forename: Shan-Shan
authors.initials: SS
authors.lastname: Guo
authors.forename: Ying-Jie
authors.initials: YJ
authors.lastname: Gao
authors.forename: Xue-Chuan
authors.initials: XC
authors.lastname: Tian
authors.forename: Ya-Hong
authors.initials: YH
authors.lastname: Jin
authors.forename: Fang-Zhou
authors.initials: FZ
authors.lastname: Liu
authors.forename: Xiao-Lan
authors.initials: XL
authors.lastname: Cui
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000139:chemically induced; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology*; D054644:Ear Auricle / Q000098:blood supply; D004731:Endotoxins; D005260:Female; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D005340:Fibrinogen / Q000378:metabolism; D008297:Male; D008833:Microcirculation; D010314:Partial Thromboplastin Time; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D011517:Prothrombin Time; D011817:Rabbits; D013607:Tablets; D013927:Thrombosis / Q000473:pathology
chemical_list: D004365:Drugs, Chinese Herbal; D004731:Endotoxins; D017395:Plasminogen Activator Inhibitor 1; D013607:Tablets; C549376:Xuebijing; D005340:Fibrinogen